| pubmed-article:8524243 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8524243 | lifeskim:mentions | umls-concept:C0242275 | lld:lifeskim |
| pubmed-article:8524243 | lifeskim:mentions | umls-concept:C0229535 | lld:lifeskim |
| pubmed-article:8524243 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:8524243 | lifeskim:mentions | umls-concept:C0086982 | lld:lifeskim |
| pubmed-article:8524243 | lifeskim:mentions | umls-concept:C0443299 | lld:lifeskim |
| pubmed-article:8524243 | lifeskim:mentions | umls-concept:C0851285 | lld:lifeskim |
| pubmed-article:8524243 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:8524243 | pubmed:dateCreated | 1996-1-19 | lld:pubmed |
| pubmed-article:8524243 | pubmed:abstractText | We have previously demonstrated that epidermal growth factor (EGF) produces activation of the rat prolactin (rPRL) promoter in GH4 neuroendocrine cells via a Ras-independent mechanism. This Ras independence of the EGF response appears to be cell rather than promoter specific. Oncogenic Ras also produces activation of the rPRL promoter when transfected into GH4 cells and requires the sequential activation of Raf kinase, mitogen-activated protein (MAP) kinase, and c-Ets-1/GHF-1 to mediate this response. In these studies, we have investigated the interaction between EGF and Ras in stimulating rPRL promoter activity and the role of Raf and MAP kinases in mediating the EGF response. We have also examined the role of several transcription factors and used various promoter mutants of the rPRL gene in order to better define the trans- and cis-acting components of the EGF response. EGF treatment of GH4 cells inhibits activation of the rPRL promoter produced by transfection of V12Ras from 24- to 4-fold in an EGF dose-dependent manner. This antagonistic effect of EGF and Ras is mutual in that transfection of V12Ras also blocks EGF-induced activation of the rPRL promoter in a Ras dose-dependent manner, from 5.5- to 1.6-fold. Transfection of a plasmid encoding the dominant-negative Raf C4 blocks Ras-induced activation by 66% but fails to inhibit EGF-mediated activation of the rPRL promoter. Similarly, transfection of a construct encoding an inhibitory form of MAP kinase decreases the Ras response by 50% but does not inhibit the EGF response. Previous studies have demonstrated that c-Ets-1 is necessary and that GHF-1 acts synergistically with c-Ets-1 in the Ras response of the rPRL promoter. In contrast, overexpression of neither c-Ets-1 nor GHF-1 enhanced EGF-mediated activation of the rPRL promoter, and dominant-negative forms of these transcription factors failed to inhibit the EGF response. Using 5' deletion and site-specific mutations, we have mapped the EGF response to two regions on the proximal rPRL promoter. One region maps between -255 and -212, near the Ras response element, and a second maps between -125 and -54. The latter region appears to involve footprint 2, a previously identified repressor site on the rPRL promoter. Neither footprint 1 nor 3, known GHF-1 binding sites, appears to be crucial to RGF-mediated rPRL promoter activation. The results of these studies indicate that in GH4 neuroendocrine cells, rPRL gene regulation by EGF is mediated by a signal transduction pathway that is separate and antagonistic to the Ras pathway. Hence, the functional role of the Ras/Raf/MAP kinase pathway in mediating transcriptional responses to EGF and other receptor tyrosine kinase may differ in highly specialized cell types. | lld:pubmed |
| pubmed-article:8524243 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8524243 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8524243 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8524243 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:8524243 | pubmed:issn | 0270-7306 | lld:pubmed |
| pubmed-article:8524243 | pubmed:author | pubmed-author:Gutierrez-Har... | lld:pubmed |
| pubmed-article:8524243 | pubmed:author | pubmed-author:PickettC ACA | lld:pubmed |
| pubmed-article:8524243 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8524243 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:8524243 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8524243 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8524243 | pubmed:pagination | 6777-84 | lld:pubmed |
| pubmed-article:8524243 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:meshHeading | pubmed-meshheading:8524243-... | lld:pubmed |
| pubmed-article:8524243 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8524243 | pubmed:articleTitle | Epidermal growth factor and Ras regulate gene expression in GH4 pituitary cells by separate, antagonistic signal transduction pathways. | lld:pubmed |
| pubmed-article:8524243 | pubmed:affiliation | Department of Medicine, University of Colorado Health Sciences Center, Denver 80262, USA. | lld:pubmed |
| pubmed-article:8524243 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8524243 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8524243 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8524243 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8524243 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8524243 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8524243 | lld:pubmed |
